KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Q3 2025 value amounting to $168.4 million.

  • Jazz Pharmaceuticals' Amortizatization of Intangibles rose 692.95% to $168.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $643.8 million, marking a year-over-year increase of 384.85%. This contributed to the annual value of $627.3 million for FY2024, which is 312.83% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Amortizatization of Intangibles of $168.4 million as of Q3 2025, which was up 692.95% from $162.1 million recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Amortizatization of Intangibles registered a high of $172.1 million during Q1 2022, and its lowest value of $68.2 million during Q1 2021.
  • Its 5-year average for Amortizatization of Intangibles is $149.8 million, with a median of $154.9 million in 2023.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Amortizatization of Intangibles surged by 15236.68% in 2022 and then tumbled by 1296.27% in 2023.
  • Quarter analysis of 5 years shows Jazz Pharmaceuticals' Amortizatization of Intangibles stood at $157.3 million in 2021, then decreased by 12.66% to $137.4 million in 2022, then increased by 10.31% to $151.6 million in 2023, then increased by 4.85% to $158.9 million in 2024, then increased by 5.96% to $168.4 million in 2025.
  • Its Amortizatization of Intangibles stands at $168.4 million for Q3 2025, versus $162.1 million for Q2 2025 and $154.4 million for Q1 2025.